Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Business Crimes BulletinFeaturesCriminal LawWhite Collar Crime

SCOTUS Hears Arguments In Doctors' Good Faith Defense to Prescribing Controlled Substances

By By Robert J. Anello and Richard F. Albert
May 01, 2022

When is a doctor a doctor and when is a doctor a drug dealer? In early March, the U.S. Supreme Court heard oral argument in two consolidated cases — Ruan v. United States and Kahn v. United States — to address where that line is drawn. Since the mid-1970s, doctors who prescribe controlled substances are not subject to prosecution for unlawful distribution under the Controlled Substances Act unless those prescriptions "fall outside the usual course of professional practice." United States v. Moore, 423 U.S. 122, 124 (1975). If a doctor prescribing controlled substances believes, mistakenly, that he or she is acting within the usual course of professional practice, that sounds like medical malpractice, but is it also a felony? The court granted certiorari in Ruan and Kahn to address a circuit split on whether a physician who prescribes controlled substances may be convicted of unlawful distribution under 21 U.S.C. §841(a)(1) without regard to whether, in good faith, that physician believed the prescriptions to fall within an acceptable course of professional practice. See, Ruan v. United States, No. 20-1410; Kahn v. United States, No. 21-5261.

The issue at stake in Ruan and Kahn seems primed to fit a pattern of recent cases where the Supreme Court has addressed interpretations of criminal statutes that threaten to sweep too far. In cases like Bond v. United States, 572 U.S. 844 (2014), Yates v. United States, 574 U.S. 528 (2015), and most recently in Van Buren v. United States, 141 S. Ct. 1648 (2021), the Supreme Court narrowly has interpreted broadly written criminal statutes based on a close — sometimes strained — analysis of statutory language. In these cases, the court, at times, has acknowledged the larger problem of overcriminalization via statutes susceptible of sweeping in innocent or de minimis conduct, but nevertheless anchors its decisions in the text — without express reliance on broader judicial doctrines. The parties' arguments and the justices' comments during oral argument in Ruan and Kahn, however, hint at the possibility that the court may break its recent pattern and delineate the boundary between medical malpractice and felony drug dealing on a more far-reaching doctrinal foundation — the bedrock criminal law principle that each statutory element distinguishing lawful from unlawful conduct must be done with mens rea.

This premium content is locked for Business Crimes Bulletin subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

Bankruptcy Sales: Finding a Diamond In the Rough Image

There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.

Compliance Officers: Recent Regulatory Guidance and Enforcement Actions and Mitigating the Risk of Personal Liability Image

This article explores legal developments over the past year that may impact compliance officer personal liability.